Injectable tissue-engineered soft tissue for tissue augmentation

Sung Mi Rhee, Hijin You, Seung-Kyu Han

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Soft tissue augmentation is a process of implanting tissues or materials to treat wrinkles or soft tissue defects in the body. Over the years, various materials have evolved to correct soft tissue defects, including a number of tissues and polymers. Autogenous dermis, autogenous fat, autogenous dermis-fat, allogenic dermis, synthetic implants, and fillers have been widely accepted for soft tissue augmentations. Tissue engineering technology has also been introduced and opened a new venue of opportunities in this field. In particular, a long-lasting filler consisting of hyaluronic acid filler and living human mesenchymal cells called "injectable tissue-engineered soft tissue" has been created and applied clinically, as this strategy has many advantages over conventional methods. Fibroblasts and adipose-derived stromal vascular fraction cells can be clinically used as injectable tissue-engineered soft tissue at present. In this review, information on the soft tissue augmentation method using the injectable tissue-engineered soft tissue is provided.

Original languageEnglish
Pages (from-to)S170-S175
JournalJournal of Korean Medical Science
Volume29
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

Injections
Dermis
Fats
Hyaluronic Acid
Tissue Engineering
Blood Vessels
Polymers
Fibroblasts
Technology

Keywords

  • Cell therapy
  • Soft tissue
  • Tissue engineering

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Injectable tissue-engineered soft tissue for tissue augmentation. / Rhee, Sung Mi; You, Hijin; Han, Seung-Kyu.

In: Journal of Korean Medical Science, Vol. 29, 01.01.2014, p. S170-S175.

Research output: Contribution to journalReview article

@article{515c3a213c484cdaac07b0f85a6e6fe5,
title = "Injectable tissue-engineered soft tissue for tissue augmentation",
abstract = "Soft tissue augmentation is a process of implanting tissues or materials to treat wrinkles or soft tissue defects in the body. Over the years, various materials have evolved to correct soft tissue defects, including a number of tissues and polymers. Autogenous dermis, autogenous fat, autogenous dermis-fat, allogenic dermis, synthetic implants, and fillers have been widely accepted for soft tissue augmentations. Tissue engineering technology has also been introduced and opened a new venue of opportunities in this field. In particular, a long-lasting filler consisting of hyaluronic acid filler and living human mesenchymal cells called {"}injectable tissue-engineered soft tissue{"} has been created and applied clinically, as this strategy has many advantages over conventional methods. Fibroblasts and adipose-derived stromal vascular fraction cells can be clinically used as injectable tissue-engineered soft tissue at present. In this review, information on the soft tissue augmentation method using the injectable tissue-engineered soft tissue is provided.",
keywords = "Cell therapy, Soft tissue, Tissue engineering",
author = "Rhee, {Sung Mi} and Hijin You and Seung-Kyu Han",
year = "2014",
month = "1",
day = "1",
doi = "10.3346/jkms.2014.29.S3.S170",
language = "English",
volume = "29",
pages = "S170--S175",
journal = "Journal of Korean Medical Science",
issn = "1011-8934",
publisher = "Korean Academy of Medical Science",

}

TY - JOUR

T1 - Injectable tissue-engineered soft tissue for tissue augmentation

AU - Rhee, Sung Mi

AU - You, Hijin

AU - Han, Seung-Kyu

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Soft tissue augmentation is a process of implanting tissues or materials to treat wrinkles or soft tissue defects in the body. Over the years, various materials have evolved to correct soft tissue defects, including a number of tissues and polymers. Autogenous dermis, autogenous fat, autogenous dermis-fat, allogenic dermis, synthetic implants, and fillers have been widely accepted for soft tissue augmentations. Tissue engineering technology has also been introduced and opened a new venue of opportunities in this field. In particular, a long-lasting filler consisting of hyaluronic acid filler and living human mesenchymal cells called "injectable tissue-engineered soft tissue" has been created and applied clinically, as this strategy has many advantages over conventional methods. Fibroblasts and adipose-derived stromal vascular fraction cells can be clinically used as injectable tissue-engineered soft tissue at present. In this review, information on the soft tissue augmentation method using the injectable tissue-engineered soft tissue is provided.

AB - Soft tissue augmentation is a process of implanting tissues or materials to treat wrinkles or soft tissue defects in the body. Over the years, various materials have evolved to correct soft tissue defects, including a number of tissues and polymers. Autogenous dermis, autogenous fat, autogenous dermis-fat, allogenic dermis, synthetic implants, and fillers have been widely accepted for soft tissue augmentations. Tissue engineering technology has also been introduced and opened a new venue of opportunities in this field. In particular, a long-lasting filler consisting of hyaluronic acid filler and living human mesenchymal cells called "injectable tissue-engineered soft tissue" has been created and applied clinically, as this strategy has many advantages over conventional methods. Fibroblasts and adipose-derived stromal vascular fraction cells can be clinically used as injectable tissue-engineered soft tissue at present. In this review, information on the soft tissue augmentation method using the injectable tissue-engineered soft tissue is provided.

KW - Cell therapy

KW - Soft tissue

KW - Tissue engineering

UR - http://www.scopus.com/inward/record.url?scp=84952665146&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84952665146&partnerID=8YFLogxK

U2 - 10.3346/jkms.2014.29.S3.S170

DO - 10.3346/jkms.2014.29.S3.S170

M3 - Review article

VL - 29

SP - S170-S175

JO - Journal of Korean Medical Science

JF - Journal of Korean Medical Science

SN - 1011-8934

ER -